Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets... see more

CSE:THC - Post Discussion

THC Biomed Intl Ltd > I can see edibles bigger profit margin. Cost of sales down
View:
Post by RamboOO7 on Apr 02, 2022 9:11am

I can see edibles bigger profit margin. Cost of sales down

Revenue $ 606,826$ ... Cost of sales $(436,672) Gross profit before fair value adjustments $170,154.......... i see in the past higher sales revenue but cost of sales was higher.because of dry flower. .. Conclusion if THC Sells more dry they have to sell this pot 20% THC and over at a descent price to balance revenue versus costs. I see revenue from edible versus cost of sales very good. Conclusion i see profit margins improving with edible sales improving. I guess this is called part of growing pains for a company. I will be looking forward to see edible revenues for THC Biomed from OCS in Q4.
Comment by RamboOO7 on Apr 02, 2022 9:11am
Q2
Comment by RamboOO7 on Apr 03, 2022 9:32pm
The way i see it JM invested $250,000 into THC Q2 jan 8. There cash balance is about $10,000 higher Q2 than Q1. So their burn rate is about $240,000 for 3 months. April 8 will be 3 months later. Will THC need another financing at this price. JM still owes about $118,000 to the company. Pay your debt before another financing . Geez.
Comment by RamboOO7 on Apr 03, 2022 9:35pm
Good news will be if THC doesn't finance by june 31. This will be Q3 financials. This means maybe their biscuits are raking in the money. DYODD
Comment by RamboOO7 on Apr 03, 2022 9:37pm
And a real profit.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities